GenScript Raises HK$2.33 Billion for AIDD Expansion
GenScript Biotech conditionally placed 77.126 million new shares at HK$30.50 each, targeting net proceeds of approximately HK$2.327 billion. About 70% is intended for artificial-intelligence-driven drug-discovery capacity and infrastructure, 20% for related research, digital-workflow integration…
